Trials / Completed
CompletedNCT04462068
ACE and HLA Genotypes Predict Severity and Disease Progression in Danish Sarcoid Patients
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 150 (actual)
- Sponsor
- University of Aarhus · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Sarcoidosis is a multisystem granulomatous disease of unknown cause histologically characterized by noncaseating granulomas. Genetic factors affect disease course, which is highly variable and difficult to predict. This study aims to evaluate the predictive value of ACE and HLA genotypes on disease severity and progression in Danish patients with sarcoidosis.
Conditions
Timeline
- Start date
- 2019-12-01
- Primary completion
- 2023-11-30
- Completion
- 2023-11-30
- First posted
- 2020-07-08
- Last updated
- 2024-01-25
Locations
1 site across 1 country: Denmark
Source: ClinicalTrials.gov record NCT04462068. Inclusion in this directory is not an endorsement.